Literature DB >> 17238470

Improving adherence to coronary heart disease secondary prevention medication guidelines at a community hospital.

Thomas C Bailey1, Laura A Noirot, Brian F Gage, Xia Li, William D Shannon, Brian Waterman, Stuti Sinha, Dennis A Bouselli, Richard M Reichley, Anne C Goldberg, Wm Claiborne Dunagan.   

Abstract

Using a two-period group randomized study, we tested whether a technology assisted pharmacist intervention improved physician adherence to coronary heart disease (CHD) secondary prevention medication guidelines. After an observation period, physician practices were randomized to intervention or control arms. In the intervention arm, alerts prompted a pharmacist to communicate with the responsible physician about secondary prevention medications. The intervention significantly improved the proportion of patients discharged on appropriate secondary prevention medications.

Entities:  

Mesh:

Year:  2006        PMID: 17238470      PMCID: PMC1839691     

Source DB:  PubMed          Journal:  AMIA Annu Symp Proc        ISSN: 1559-4076


  2 in total

1.  AHA/ACC Scientific Statement: AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: A statement for healthcare professionals from the American Heart Association and the American College of Cardiology.

Authors:  S C Smith; S N Blair; R O Bonow; L M Brass; M D Cerqueira; K Dracup; V Fuster; A Gotto; S M Grundy; N H Miller; A Jacobs; D Jones; R M Krauss; L Mosca; I Ockene; R C Pasternak; T Pearson; M A Pfeffer; R D Starke; K A Taubert
Journal:  Circulation       Date:  2001-09-25       Impact factor: 29.690

2.  Implementation of an automated guideline monitor for secondary prevention of acute myocardial infarction.

Authors:  Laura A Noirot; Amy Blickensderfer; Erin Christensen; Robyn Schaiff; Anthony Kessels; Alan Braverman; Anne Goldberg; William Claiborne Dunagan; Thomas C Bailey
Journal:  Proc AMIA Symp       Date:  2002
  2 in total
  2 in total

1.  Improving care of post-infarct patients: effects of disease management programmes and care according to international guidelines.

Authors:  Renee Stark; Inge Kirchberger; Matthias Hunger; Margit Heier; Reiner Leidl; Wolfgang von Scheidt; Christa Meisinger; Rolf Holle
Journal:  Clin Res Cardiol       Date:  2013-11-28       Impact factor: 5.460

2.  The Impact of Clinical Pharmacist Support on Patients Receiving Multi-drug Therapy for Coronary Heart Disease in China.

Authors:  S J Zhao; H W Zhao; S Du; Y H Qin
Journal:  Indian J Pharm Sci       Date:  2015 May-Jun       Impact factor: 0.975

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.